E leven clinics, hospitals and doctor's offices in New York, Montana, California, Maryland, Georgia, Nebraska, Vermont, and Washington state have access to a U.S.-made clone of RU 486, the "French abortion pill," through an FDA-approved research project. Abortion Rights Mobilization, a nonprofit organization which is conducting the mifepristone trials through which the drug is available, released names and phone numbers of all the clinics and hospitals to family planning and women's rights groups. For a list of clinics see the Feminist Majority Foundation web site: /rrights/mifeptrials.html.

Sixteen hundred women have thus far been treated in the trials. ARM plans to treat at least 10,000 women. Preliminary results of a study based on the ARM trials found a high success rate using 1/3 the dosage of RU 486 compared to the dosage used in European clinics and hospitals. €